Related Experiment Video

Updated: Apr 30, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

7.1K

Restoration of miR17/20a in solid tumor cells enhances the natural killer cell antitumor activity by targeting Mekk2

Hong Jiang1, Ping Wang2, Xiaohua Li3

  • 1Louisville Veterans Administration Medical Center; James Graham Brown Cancer Center; H0Zhan17@louisville.edu hongjiang.res@gmail.com.

Cancer Immunology Research
|May 8, 2014
PubMed

Insights

Restoring miR17/20a microRNA expression suppresses solid tumors by enhancing natural killer cell recognition. This mechanism involves inhibiting MHC class I expression via the Mekk2-Mek5-Erk5 pathway, reprogramming cancer cells for immune attack.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Aberrant microRNA (miRNA) expression is common in human solid cancers.
  • The role of miRNA expression levels in tumor progression remains unclear.
  • The miR17-92 cluster is frequently dysregulated in various cancers.

Purpose of the Study:

  • To investigate the function of the miR17-92 cluster, specifically miR17/20a, in solid tumor progression.
  • To determine if restoring miRNA expression can impact tumor growth and immune recognition.
  • To elucidate the molecular mechanisms underlying miRNA-mediated tumor suppression.

Main Methods:

  • Genetically engineered murine breast and colon cancer cells to express higher levels of miR17/20a.
  • Assessed natural killer (NK)-cell recognition and cytotoxicity.
  • Investigated the role of the Mekk2-Mek5-Erk5 pathway and MHC class I (H-2D) expression.
  • Validated findings in human solid tumor samples.

Main Results:

  • Restoration of miR17/20a expression in murine cancer cells led to tumor suppression.
  • Increased miR17/20a levels enhanced NK-cell recognition by downregulating MHC class I (H-2D) expression.
  • This downregulation was mediated through the Mekk2-Mek5-Erk5 signaling pathway.
  • The observed effects in murine models were consistent with human solid tumor samples.

Conclusions:

  • miR17/20a microRNAs function as tumor suppressors in solid cancers.
  • These miRNAs reprogram tumor cells to be susceptible to NK cell-mediated killing.
  • The findings highlight a novel mechanism of miRNA-driven tumor immune evasion and suppression.

More Related Videos

Measurement of Natural Killer Cell-Mediated Cytotoxicity and Migration in the Context of Hepatic Tumor Cells06:55

Measurement of Natural Killer Cell-Mediated Cytotoxicity and Migration in the Context of Hepatic Tumor Cells

Published on: February 22, 2020

21.0K
Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells11:08

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on: February 14, 2025

1.9K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.0K